Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Non-Executive Director Laurence Ede was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Aug 25
First half 2022 earnings released: EPS: UK£0 (vs UK£0.001 loss in 1H 2021) First half 2022 results: EPS: UK£0. Revenue: UK£678.0k (up 4.5% from 1H 2021). Net loss: UK£1.81m (loss widened 32% from 1H 2021). Reported Earnings • Apr 27
First half 2021 earnings released: UK£0.001 loss per share (vs UK£0.002 loss in 1H 2020) First half 2021 results: UK£0.001 loss per share. Revenue: UK£649.0k (up 21% from 1H 2020). Net loss: UK£1.38m (loss widened 18% from 1H 2020). Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Non-Executive Chairman Karen Bach was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Sep 24
First half 2021 earnings released: UK£0.001 loss per share (vs UK£0.002 loss in 1H 2020) The company reported a solid first half result with improved revenues and control over costs, although losses increased. First half 2021 results: Revenue: UK£649.0k (up 21% from 1H 2020). Net loss: UK£1.38m (loss widened 18% from 1H 2020). Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 26% per year, which means it is significantly lagging earnings. Reported Earnings • Jun 03
Full year 2020 earnings released: UK£0.003 loss per share (vs UK£0.004 loss in FY 2019) The company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2020 results: Revenue: UK£1.32m (up 10% from FY 2019). Net loss: UK£2.41m (loss narrowed 20% from FY 2019). Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has fallen by 13% per year, which means it is performing significantly worse than earnings. お知らせ • Mar 12
Deepmatter Group plc Signs Co-Distribution Agreement with Elemental Machines DeepMatter Group plc announced that it has signed a co-distribution agreement with Elemental Machines. This agreement will see Elemental Machines promote DeepMatter's integrated software, hardware and artificial intelligence enabled platform, DigitalGlassware®, to its wide network of small and mid-size biotech North American customers through its sales team, presenting the Group with the opportunity to broaden its customer base and help establish sales opportunities across North America with organizations in the pharmaceutical and biotechnology sectors. DeepMatter will promote Elemental Machines' sensor-based products to its established European network who are interested in a wider sphere of real-time digital inputs for monitoring their laboratory environment, thereby expanding the number of laboratory devices which can integrate with the DigitalGlassware® platform. Executive Departure • Mar 10
Non-Executive Director has left the company On the 9th of March, Bettina Goerner's tenure as Non-Executive Director ended after 2.0 years in the role. We don't have any record of a personal shareholding under Bettina's name. A total of 3 executives have left over the last 12 months. お知らせ • Mar 10
DeepMatter Group Plc Announces Directorate Changes DeepMatter Group plc announced that Mirko Walter has been appointed to the Board as Non-Executive Director with immediate effect. Mirko is currently Vice President Sales of Springer Nature, the global academic publishing company, and has been with the business for six years, supporting the company's growth strategy through sales excellence, partnerships and portfolio expansion. Mirko succeeds Bettina Goerner, who has stepped down from her operational role at Springer Nature, and therefore will step down from the DeepMatter Board effective immediately. お知らせ • Dec 18
DeepMatter Group Plc Announces Multi-Year Contract with Thieme Chemistry DeepMatter Group plc announced that it has signed a three-year contract with Thieme Chemistry, which is part of the Thieme Group, an award-winning international medical and science publisher serving health professionals and students for more than 130 years, for the supply of technical data services and access to the Group's proprietary algorithms. The contract builds on a long-standing relationship between the two businesses, providing Thieme with access to DeepMatter's services and algorithms to ensure the quality of, and access to, their data. お知らせ • Oct 16
Deepmatter Secures Contracts with Five New Major Customers over the Last Two Months for ICSYNTH DeepMatter announced it has secured contracts with five new major customers over the last two months for its powerful computer aided synthesis design tool, ICSYNTH. In total, ICSYNTH customer numbers have more than doubled through the course of 2020, and the Company has achieved 100% customer renewals, adding to the Group's underlying revenue base. The new customers include some of the multi-national pharmaceutical, agrisciences, biotech and contract research organizations (CROs). Retrosynthesis is a growing area of the Life Sciences Research & Development space, providing an increasing opportunity for ICSYNTH. ICSYNTH is a powerful computer aided synthesis design tool that enables chemists to generate synthetic pathways for a target molecule, leading to better, faster and more cost-effective synthesis predictions. ICSYNTH facilitates innovation by stimulating ideas for alternative or novel synthetic routes that otherwise may not be considered by the chemist. Development work has recently been completed on a new User Interface for the tool, facilitating greater ease of use, and new algorithms have been introduced to filter out erroneous data from any data source, including proprietary data in Electronic Laboratory Notebooks, leading to improved synthesis predictions resulting in better productivity and time management. お知らせ • Sep 04
DeepMatter Group Plc to Report First Half, 2020 Results on Sep 10, 2020 DeepMatter Group Plc announced that they will report first half, 2020 results on Sep 10, 2020 お知らせ • Jul 17
DeepMatter Group Plc has completed a Follow-on Equity Offering in the amount of £2.13845 million. DeepMatter Group Plc has completed a Follow-on Equity Offering in the amount of £2.13845 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 142,563,335
Price\Range: £0.015
Transaction Features: Subsequent Direct Listing